Tumor histology was predominantly adenocarcinoma, with a small number (N=3) of acinar and adenosquamous carcinomas in Cohort A. Baseline CA19–9 and CEA values at enrollment were similar between cohort A and B but higher in Cohort C, consistent with greater disease burden. The gene discussed is CEACAM5; the disease is adenosquamous carcinoma.